These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21688620)

  • 41. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
    Scheiman JM; Hindley CE
    Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
    Lanas A; Hunt R
    Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment and prevention of gastrointestinal complications caused by non-steroidal antiphlogistic agents].
    Rybár I; Kriska M; Vavrecka A; Hyrdel R; Rovenský J
    Cas Lek Cesk; 1999 Nov; 138(22):675-80. PubMed ID: 10746025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathogenesis of NSAIDs-induced gastrointestinal ulcers].
    Yoshikawa T; Naito Y
    Nihon Rinsho; 2011 Jun; 69(6):995-1002. PubMed ID: 21688618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention.
    Vonkeman HE; van de Laar MA
    Semin Arthritis Rheum; 2010 Feb; 39(4):294-312. PubMed ID: 18823646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Non-steroidal antiinflammatory drug--management of gastrointestinal complications and inhibition of COX-2].
    Tada Y; Nagasawa K
    Nihon Rinsho; 1999 Feb; 57(2):419-24. PubMed ID: 10078017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM
    Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
    Agrawal N
    J Fam Pract; 1991 Jun; 32(6):619-24. PubMed ID: 2040888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevention and treatment of NSAIDs-induced gastrointestinal complications by prostaglandin derivatives].
    Suzuki Y; Saito E; Wakabayashi T; Suwa A
    Nihon Rinsho; 2007 Oct; 65(10):1843-9. PubMed ID: 17926534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevention and therapy of NSAID-induced ulcers: fact versus myth].
    Fried M; Bertschinger P
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1569-72. PubMed ID: 8927961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment and prevention of histamine-2 receptor antagonist for elderly gastric ulcer].
    Kamada T; Sato Y; Shiotani A; Haruma K
    Nihon Rinsho; 2010 Nov; 68(11):2064-70. PubMed ID: 21061534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention of Non-steroidal Anti-inflammatory Drug-induced Peptic Ulcers].
    Chu SJ; Yoon KT; Kim JS
    Korean J Gastroenterol; 2020 Nov; 76(5):232-237. PubMed ID: 33234769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Actual status and vision of NSAIDs-induced intestinal injuries].
    Fujimori S; Sakamoto C
    Nihon Rinsho; 2011 Jun; 69(6):1075-82. PubMed ID: 21688631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal effects of NSAIDs. Difficulties in detection and management.
    Pearson SP; Kelberman I
    Postgrad Med; 1996 Nov; 100(5):131-2, 135-6, 141-3. PubMed ID: 8917329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current Topics of Strategy of NSAID-Induced Small Intestinal Lesions.
    Edogawa S; Takeuchi T; Kojima Y; Ota K; Harada S; Kuramoto T; Narabayashi K; Inoue T; Higuchi K
    Digestion; 2015; 92(2):99-107. PubMed ID: 26279152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers with proton pump inhibitor].
    Tsuji Y; Itoh T; Chiba T
    Nihon Rinsho; 2007 Oct; 65(10):1831-4. PubMed ID: 17926532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pathogenic mechanism of NSAIDs-induced mucosal injury in lower gastrointestinal tract].
    Beppu K; Osada T; Shibuya T; Watanabe S
    Nihon Rinsho; 2011 Jun; 69(6):1083-7. PubMed ID: 21688632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton pump inhibitors--their pharmacological impact on the clinical management of acid-related disorders.
    Klotz U
    Arzneimittelforschung; 2009; 59(6):271-82. PubMed ID: 19634508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.